Novo Nordisk Highlights New Wegovy Pill Data – Novo Nordisk (NYSE:NVO)
The company said adults treated with oral semaglutide 25 mg achieved clinically meaningful weight loss regardless of whether…
Novo Nordisk Presents New Wegovy Data Showing Strong Weight Loss, Fat Reduction – Novo Nordisk (NYSE:NVO)
The company also said a separate analysis showed most of the weight lost with Wegovy came from body…
CMS To Offer Wegovy To Eligible Medicare Patients At $50 Monthly Copay Starting July 2026 – Novo Nordisk
The Centers for Medicare & Medicaid Services announced that eligible Medicare beneficiaries living with obesity will gain access…
Wegovy Pill Debut ‘Fattens’ Novo Nordisk’s Profit Outlook – Novo Nordisk (NYSE:NVO)
The weight loss drug maker reported first quarter sales of $15.17 billion (96.82 billion Danish kroner), beating the…
Data Center Boom Meets Energy Limits As Denmark Halts New Projects Amid AI-Driven Power Crisis – Alphabet
Denmark’s temporary halt on new grid connections for data centers underscores how soaring AI and cloud infrastructure demand…
What’s Going On With Greenland Energy Stock Thursday? – Greenland Energy (NASDAQ:GLND)
Greenland Energy Co. (NASDAQ:GLND) shares are up during Thursday’s premarket session. Highlights Arctic Strategy The company said Tuesday…
Greenland Energy Stock Soars 27% After Halliburton Deal – Greenland Energy (NASDAQ:GLND)
Deal Highlights The agreement covers integrated consulting services and logistical management, including planning, coordination, handling and transportation of…
Novo Nordisk Shares Rise After Positive Oral Semaglutide Trial In Children – Novo Nordisk (NYSE:NVO)
Trial Results Show Significant Blood Sugar Reduction Novo Nordisk said its phase 3a PIONEER TEENS trial demonstrated a…
What’s Going On With Novo Nordisk Stock Thursday? – Novo Nordisk (NYSE:NVO)
Oral Semaglutide Shows Superior Glycaemic Control The phase 3a study evaluated oral semaglutide in patients aged 10–17 years…
Novo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake – Eli Lilly (NYSE:LLY)
Early Prescription Trends Show Slower Start For Lilly Reuters, citing IQVIA data, reported that Eli Lilly recorded 1,390…
GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market – GoodRx Holdings (NASDAQ:GDRX), Novo Nordisk
• GoodRx Holdings shares are advancing steadily. What’s driving GDRX shares up? This move comes amid a growing…
Move Over Novo Nordisk – This Small Company Study Flags Edge In Fatty Liver Drug – Hoth Therapeutics (NAS
Hoth Therapeutics Candidate Shows Impact On Fat Production And Metabolism The HT-VA study demonstrated that parenteral GDNF (Glial…